Cleveland
Cleveland’s SPR Therapeutics raises $85M for non-opioid pain treatment option
[caption id align="alignnone" width="1535"] Photo credit: SPR Therapeutics, Inc. [/caption] Cleveland’s SPR Therapeutics has raised $85 million to provide patients with a non-opioid, minimally invasive pain treatment option. The financing round, led by Revelation Partners with participation from RC Capital and Mutual Capital